Keros Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $255.3M
Liabilities Breakdown FY2021
Total Liabilities: $12.1M
Asset Breakdown
Total Assets: $255.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $230.0M | 90.1% |
| Accounts Receivable | $18.0M | 7.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.3M | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $5.9M | 2.3% |
Liabilities Breakdown
Total Liabilities: $12.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.6M | 30.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.4M | 69.8% |